JOHN B HENNEMAN III Insider Trading $AH R1 RCM INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN B HENNEMAN III.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN B HENNEMAN III. JOHN B HENNEMAN III is Director in Anika Therapeutics, Inc. ($ANIK) and Chief Administrative Officer in NEWLINK GENETICS CORP ($NLNK) and EVP, Chief Financial Officer in NEWLINK GENETICS CORP ($NLNK) and Director in Accretive Health, Inc. ($AH) and Director in SeaSpine Holdings Corp ($SPNE) and in Aprea Therapeutics, Inc. ($APRE).
JOHN B HENNEMAN III in R1 RCM INC.
Trading Symbol: AHIndustry: SERVICES-MANAGEMENT SERVICES [8741]
Position of JOHN B HENNEMAN III: Director
Holdings: 100 shares
Latest Transaction: May 24 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN B HENNEMAN III in R1 RCM INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANIK, APRE, NLNK, AH, SPNE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 24 2021 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 0.00 | 5,151 | 0 | 5,151 | |
Apr 02 2021 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 24.98 | 1,490 | 37,220 | 1,490 | |
Jan 05 2021 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 23.49 | 1,625 | 38,171 | 1,625 | |
Oct 02 2020 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 17.54 | 2,186 | 38,342 | 2,186 | |
Jul 02 2020 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 11.78 | 3,249 | 38,273 | 3,249 | |
Apr 03 2020 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 8.41 | 4,542 | 38,198 | 4,542 | |
Apr 03 2020 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 8.41 | 4,542 | 38,198 | 4,542 | |
Jan 03 2020 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 12.69 | 2,851 | 36,179 | 2,851 | |
Jan 03 2020 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 12.69 | 2,851 | 36,179 | 2,851 | |
Oct 03 2019 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 9.05 | 4,025 | 36,426 | 4,025 | |
Jul 02 2019 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 12.65 | 2,846 | 36,002 | 2,846 | |
Apr 02 2019 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 9.57 | 3,684 | 35,256 | 3,684 | |
Jan 03 2019 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 7.89 | 4,285 | 33,809 | 4,285 | |
Oct 03 2018 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 10.01 | 3,319 | 33,223 | 3,319 | |
Apr 03 2018 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 7.07 | 4,770 | 33,724 | 4,770 | |
Oct 03 2017 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 3.76 | 9,169 | 34,475 | 9,169 | |
Apr 05 2017 | AH | R1 RCM INC. | HENNEMAN JOHN B III | Director | Option Exercise | A | 3.08 | 10,512 | 32,377 | 10,512 | |
Jan 04 2017 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Option Exercise | A | 2.29 | 14,098 | 32,284 | 14,098 | |
Oct 05 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Option Exercise | A | 2.42 | 13,762 | 33,304 | 13,762 | |
Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.80 | 12,500 | 22,500 | 50,000 | 37.5 K to 50 K (+33.33 %) |
Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.80 | 1,500 | 2,700 | 37,500 | 36 K to 37.5 K (+4.17 %) |
Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.81 | 14,500 | 26,245 | 36,000 | 21.5 K to 36 K (+67.44 %) |
Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.81 | 1,500 | 2,715 | 21,500 | 20 K to 21.5 K (+7.50 %) |
Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.80 | 10,000 | 17,975 | 20,000 | 10 K to 20 K (+100.00 %) |
Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.80 | 7,800 | 14,040 | 10,000 | 2.2 K to 10 K (+354.55 %) |
Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.79 | 500 | 895 | 2,200 | 1.7 K to 2.2 K (+29.41 %) |
Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.77 | 500 | 885 | 1,700 | 1.2 K to 1.7 K (+41.67 %) |
Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.79 | 500 | 893 | 1,200 | 700 to 1.2 K (+71.43 %) |
Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.77 | 100 | 177 | 700 | 600 to 700 (+16.67 %) |
Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.79 | 500 | 895 | 600 | 100 to 600 (+500.00 %) |
Aug 17 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Buy | P | 1.78 | 100 | 178 | 100 | 0 to 100 |
Jul 06 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Option Exercise | A | 2.00 | 15,385 | 30,770 | 15,385 | |
Apr 05 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Option Exercise | A | 2.53 | 12,048 | 30,481 | 12,048 | |
Feb 24 2016 | AH | Accretive Health, ... | HENNEMAN JOHN B III | Director | Option Exercise | A | 2.61 | 405,111 | 1,057,340 | 405,111 |
Page: 1